Atlas Trials

Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical Study

Clinical trial NCT05381636 · UNKNOWN

Trial details

NCT number
NCT05381636
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Start date
2022-06-01
Primary completion
2023-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.